Article

Cancer apps

Author(s):

Last summer, the National Cancer Institute and the Office for the National Coordinator for Health Information Technology challenged innovators to create applications that help cancer patients, survivors and healthcare professionals. The winners were recently announced and were each awarded $20,000 to develop their technology. Although these apps are still in the early stages of development, you can test some out and see what the future may look like for technology that helps us along the cancer journey. Here are the two winners:1. Ask Dory! was developed by Chintan Patel, PhD, and Sharib Kahn, MD, of Applied Informatics to help patients find clinical trials. It utilizes information from clinicaltrials.gov and takes you through a decision tree, or series of questions, to personalize and find the best trial for you. Dory was named after the curious fish in "Finding Nemo." 2. My Cancer Genome was developed by researchers at Vanderbilt-Ingram Cancer Center as a personalized support tool to help patients, caregivers and healthcare providers match genetic mutations to therapies, treatments and clinical trials. Developers have started with cancers that are known to have genetic links and plan to add new content as more genes and diseases are connected and as more targeted therapies emerge. The semifinalists also had intriguing ideas. One program focuses on cancer screening and decision making, and the other plans to provide personalized strategies for reducing cancer risk. If you are interested in seeing the semifinalists, you can look here. Congratulations to these innovators who are working to use the latest technology to make cancer more understandable and personalized!

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Image of doctor with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.